Mechanistic PBPK Modelling to Predict the Advantage of the Salt Form of a Drug When Dosed with Acid Reducing Agents
Acid reducing agents (ARAs) reduce the dissolution rate of weakly basic drugs in the stomach potentially leading to lower bioavailability. Formulating the API as a rapidly dissolving salt is one strategy employed to reduce the impact of ARAs on dissolution of such drugs. In the present work, a model...
Saved in:
Main Authors: | Siri Kalyan Chirumamilla (Author), Venkatesh Teja Banala (Author), Masoud Jamei (Author), David B. Turner (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2021-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Population PBPK modeling using parametric and nonparametric methods of the Simcyp Simulator, and Bayesian samplers
by: Janak R. Wedagedera, et al.
Published: (2022) -
Where Do PBPK Models Stand in Pharmacometrics and Systems Pharmacology?
by: Masoud Jamei
Published: (2020) -
Understanding Discordance between In Vitro Dissolution, Local Gut and Systemic Bioequivalence of Budesonide in Healthy and Crohn's Disease Patients through PBPK Modeling
by: Chunyan Han, et al.
Published: (2023) -
Application of Physiologically Based Pharmacokinetic (PBPK) Modeling Within a Bayesian Framework to Identify Poor Metabolizers of Efavirenz (PM), Using a Test Dose of Efavirenz
by: Manoranjenni Chetty, et al.
Published: (2018) -
PBPK Evaluation of Sofosbuvir Dose in Pediatrics Using Simcyp<sup>®</sup>
by: Rania Elkeeb, et al.
Published: (2023)